Evolent Health Inc
NYSE:EVH

Watchlist Manager
Evolent Health Inc Logo
Evolent Health Inc
NYSE:EVH
Watchlist
Price: 8.96 USD -2.93% Market Closed
Market Cap: 1B USD

Intrinsic Value

The intrinsic value of one EVH stock under the Base Case scenario is 27.4 USD. Compared to the current market price of 8.96 USD, Evolent Health Inc is Undervalued by 67%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

EVH Intrinsic Value
27.4 USD
Undervaluation 67%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Evolent Health Inc

EVH
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for EVH cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about EVH?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Evolent Health Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Evolent Health Inc

Current Assets 607.1m
Cash & Short-Term Investments 104.2m
Receivables 414.7m
Other Current Assets 88.2m
Non-Current Assets 1.9B
Long-Term Investments 8.6m
PP&E 79.3m
Intangibles 1.8B
Other Non-Current Assets 31.9m
Efficiency

Free Cash Flow Analysis
Evolent Health Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Evolent Health Inc

Revenue
2.6B USD
Cost of Revenue
-2.2B USD
Gross Profit
367.4m USD
Operating Expenses
-369.9m USD
Operating Income
-2.6m USD
Other Expenses
-90.9m USD
Net Income
-93.5m USD
Fundamental Scores

EVH Profitability Score
Profitability Due Diligence

Evolent Health Inc's profitability score is 43/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Gross Profit
Exceptional 1-Year Revenue Growth
Negative Free Cash Flow
43/100
Profitability
Score

Evolent Health Inc's profitability score is 43/100. The higher the profitability score, the more profitable the company is.

EVH Solvency Score
Solvency Due Diligence

Evolent Health Inc's solvency score is 32/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Positive Net Debt
32/100
Solvency
Score

Evolent Health Inc's solvency score is 32/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

EVH Price Targets Summary
Evolent Health Inc

Wall Street analysts forecast EVH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EVH is 18.23 USD with a low forecast of 12.12 USD and a high forecast of 49.57 USD.

Lowest
Price Target
12.12 USD
35% Upside
Average
Price Target
18.23 USD
103% Upside
Highest
Price Target
49.57 USD
453% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Evolent Health Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for EVH is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

EVH Insider Trading
Buy and sell transactions by insiders

EVH News

Other Videos
What is the Intrinsic Value of one EVH stock?

The intrinsic value of one EVH stock under the Base Case scenario is 27.4 USD.

Is EVH stock undervalued or overvalued?

Compared to the current market price of 8.96 USD, Evolent Health Inc is Undervalued by 67%.

Back to Top